| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Guardant Health, Inc. (GH) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 49 sells. GH is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.03M | $261.30M | -100,000 | |
| Other | 79.1K | $10.19M | - | |
| CFO | 47.5K | $6.12M | -2,000 | |
| Other | 46.7K | $6.02M | - | |
| Other | 36.0K | $4.63M | -10,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2019 | Meresman Stanley J75 | Director | Sale+OE | 5,000 | $71.50 | $357,500.00 | -79.3% | |
| Dec 3, 2019 | Clark Ian T66 | Director | Sale+OE | 2,690 | $72.78 | $195,778.20 | -67.4% | |
| Nov 26, 2019 | Talasaz Amirali | Chairman, President And COO | Sale+OE | 4,206 | $80.19 | $337,279.14 | -0.1% | |
| Nov 25, 2019 | Clark Ian T66 | Director | Sale+OE | 538 | $78.17 | $42,055.46 | -29.2% | |
| Nov 25, 2019 | Talasaz Amirali | Chairman, President And COO | Sale+OE | 46,934 | $80.19 | $3,763,558.98 | -0.7% | |
| Nov 21, 2019 | Kaul Samir | Director | Sell | 27,423 | $79.05 | $2,167,788.15 | -48.8% | |
| Nov 21, 2019 | Meresman Stanley J75 | Director | Sale+OE | 8,000 | $78.65 | $629,200.00 | -86.0% | |
| Nov 20, 2019 | Talasaz Amirali | Chairman, President And COO | Sale+OE | 174,219 | $78.85 | $13,738,017.82 | -0.7% | |
| Nov 20, 2019 | Talasaz Amirali | Chairman, President And COO | Sell | 1,310 | $79.34 | $103,940.01 | -5.7% | |
| Nov 19, 2019 | Meresman Stanley J75 | Director | Sale+OE | 10,000 | $77.99 | $779,888.80 | -37.8% |